Recently, Wolf et al. reported a confirmed response to BGJ398, an FGFR inhibitor, in a squamous cell carcinoma patient whose tumor had an FGFR1/CEP8 ratio of 2.6 by FISH [6]. This evidence concerns the gene FGFR1 and neoplasm.